Delivery Order SPE2DB22D3004-SPE2DB24FNE88
Award Date 10/19/23
Potential Completion Date 10/20/23
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,151.68, is for the delivery of Lidocaine HCL 4% Solution 4ML, a critical medical commodity. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of April 3, 2025. This award does not have a set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp. is a $1,079.27 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The contract is for the provision of 4% Lidocaine HCL solution, a common local anesthetic medication. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. The IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,057 firm fixed-price delivery order is for the supply of 4% Lidocaine HCL solution, a medical product used in various healthcare settings. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,019.45 firm fixed-price delivery order is for the supply of 4% lidocaine HCL solution (4 ml) to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a specific pharmaceutical product - Lidocaine HCL 4% Solution 50ML. The contract award has a ceiling value of $1,095.78 and was issued as a Delivery Order. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,191.54 firm fixed price delivery order is for the supply of 4% lidocaine hydrochloride solution (4 ml) to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,233.85, is for the delivery of Lidocaine HCL 1% Vial 10ML medical supplies. The contract is structured as a Firm Fixed Price Delivery Order and has an ultimate completion date of January 29, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award, valued at $6,214.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,611,525 units of Lidocaine HCL 2% Luer-Jet 5ML, a medical product used in various healthcare applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award, valued at $6,379.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 2% 200 MG/10 ML 10ML, a medical product. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of a lidocaine hydrochloride 4% solution. The $2,022.64 delivery order is a firm-fixed price contract with a completion date of May 31, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...